Efficacy and Safety of SSGJ-608 in Moderate-to-Severe Plaque Psoriasis: A Pivotal Multicenter, Double-Blind, Placebo-Controlled, Randomized, Phase III Clinical Trial.

Han L, Qin H, Lu X, Zhang L, Li L, Han H, Wang J, Duan X, Sun D, Yang W, Ren H, Wang X, Ci C, Wang Y, Han X, Yin W, Yu C, Zhang M, Zhu J, Wu L, Meng Z, Zeng T, Wang H, Shan Y, Ding Y, Feng W, Zhang X, Zhang G, Guo Q, Cheng H, Ji C, Fang R, Dong X, Zhu X, Lei T, Yang X, Xiao R, Liu Z, Tao X, Chen R, Lou J, Liu Y, Zhang J, Xu J

Open source

DOI
10.1007/s40257-026-01057-8
Published
2026 Aug 18
Container
American journal of clinical dermatology
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s40257-026-01057-8,
  title = {Efficacy and Safety of SSGJ-608 in Moderate-to-Severe Plaque Psoriasis: A Pivotal Multicenter, Double-Blind, Placebo-Controlled, Randomized, Phase III Clinical Trial.},
  author = {Han L and Qin H and Lu X and Zhang L and Li L and Han H and Wang J and Duan X and Sun D and Yang W and Ren H and Wang X and Ci C and Wang Y and Han X and Yin W and Yu C and Zhang M and Zhu J and Wu L and Meng Z and Zeng T and Wang H and Shan Y and Ding Y and Feng W and Zhang X and Zhang G and Guo Q and Cheng H and Ji C and Fang R and Dong X and Zhu X and Lei T and Yang X and Xiao R and Liu Z and Tao X and Chen R and Lou J and Liu Y and Zhang J and Xu J},
  year = {2026},
  journal = {American journal of clinical dermatology},
  doi = {10.1007/s40257-026-01057-8},
  url = {https://doi.org/10.1007/s40257-026-01057-8}
}

RIS

TY  - JOUR
TI  - Efficacy and Safety of SSGJ-608 in Moderate-to-Severe Plaque Psoriasis: A Pivotal Multicenter, Double-Blind, Placebo-Controlled, Randomized, Phase III Clinical Trial.
AU  - Han L
AU  - Qin H
AU  - Lu X
AU  - Zhang L
AU  - Li L
AU  - Han H
AU  - Wang J
AU  - Duan X
AU  - Sun D
AU  - Yang W
AU  - Ren H
AU  - Wang X
AU  - Ci C
AU  - Wang Y
AU  - Han X
AU  - Yin W
AU  - Yu C
AU  - Zhang M
AU  - Zhu J
AU  - Wu L
AU  - Meng Z
AU  - Zeng T
AU  - Wang H
AU  - Shan Y
AU  - Ding Y
AU  - Feng W
AU  - Zhang X
AU  - Zhang G
AU  - Guo Q
AU  - Cheng H
AU  - Ji C
AU  - Fang R
AU  - Dong X
AU  - Zhu X
AU  - Lei T
AU  - Yang X
AU  - Xiao R
AU  - Liu Z
AU  - Tao X
AU  - Chen R
AU  - Lou J
AU  - Liu Y
AU  - Zhang J
AU  - Xu J
PY  - 2026
JO  - American journal of clinical dermatology
DO  - 10.1007/s40257-026-01057-8
UR  - https://doi.org/10.1007/s40257-026-01057-8
ER  - 

APA

L, H., H, Q., X, L., L, Z., L, L., H, H., J, W., X, D., D, S., W, Y., H, R., X, W., C, C., Y, W., X, H., W, Y., C, Y., M, Z., J, Z., L, W., Z, M., T, Z., H, W., Y, S., Y, D., W, F., X, Z., G, Z., Q, G., H, C., C, J., R, F., X, D., X, Z., T, L., X, Y., R, X., Z, L., X, T., R, C., J, L., Y, L., J, Z., & J, X. (2026). Efficacy and Safety of SSGJ-608 in Moderate-to-Severe Plaque Psoriasis: A Pivotal Multicenter, Double-Blind, Placebo-Controlled, Randomized, Phase III Clinical Trial.. American journal of clinical dermatology. https://doi.org/10.1007/s40257-026-01057-8

Source records